Pure Global

Ambu® Neuroline Inoject Needle Electrodes - HSA Registration DE0508485

Access comprehensive regulatory information for Ambu® Neuroline Inoject Needle Electrodes in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0508485 and owned by Ambu A/S. The device was registered on September 13, 2023.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS B
DE0508485
Ambu® Neuroline Inoject Needle Electrodes
HSA Registration Number: DE0508485
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

Electromyography (EMG) Needle Electrode designed for Botulinum Toxin therapy during nerve block procedures. For single use only.

Device Classification
Device Class
CLASS B
Medical Speciality Area
General Hospital
Registration Information
Registration Number
DE0508485
Registration Date
September 13, 2023
Retention Due Date
September 12, 2025
Product Owner
Short Name
Ambu A/S
Address
Baltorpbakken 13, DK-2750 Ballerup, DENMARK
Registrant
Address
3 ANG MO KIO STREET 62, LINK@AMK, #06-15, SINGAPORE 569139
Importer
Address
3 ANG MO KIO STREET 62, LINK@AMK, #06-15, SINGAPORE 569139
Model Information
Model Name(s)
Ambu® Neuroline Inoject Needle Electrodes Ambu® Neuroline Inoject Needle Electrodes Ambu® Neuroline Inoject Needle Electrodes Ambu® Neuroline Inoject Needle Electrodes Ambu® Neuroline Inoject Needle Electrodes Ambu® Neuroline Inoject Needle Electrodes
Model Identifier(s)
74425-30/10 74430-36/10 74435-40/10 74438-45/10 74450-50/10 74475-55/10